“nivolumab” Archives

in
Entry Author Date Location
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
Freeline Therapeutics and Checkmate Pharma Make Opening IPO Moves 07/21/20 Europe
Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal 01/16/20 Boston
Roche Notches FDA Nod in Lung Cancer, Amps Up Competition With Merck 12/04/19 San Francisco
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
Bristol, With Another Lung Cancer Flop, Loses More Ground to Merck 07/24/19 New York
Bio Roundup: Merger Drama, FDA Trauma, Big IPOs, CRISPR Fights & More 06/28/19 National
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More 06/05/19 National
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer? 05/30/19 National
Immunotherapy Is Now Here For Breast Cancer. What Are Its Prospects? 05/29/19 National
Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More 05/10/19 National
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Merck Wins FDA Nod for Combo Therapy in Advanced Kidney Cancer 04/22/19 New York
AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results 04/03/19 National
In Another Lung Cancer Setback, Bristol Yanks FDA App For Drug Combo 01/24/19 New York
Failed Clinical Trial Puts Eli Lilly Cancer Drug in Limbo 01/18/19 Indiana
Bio Roundup: Aimmune Drama, Shutdown Blues, Perlmutter Talks Cancer 01/18/19 National
Five Prime’s Shakeup Cuts Staff 20%, Keeps Focus on Clinical Programs 01/15/19 San Francisco
Gates Foundation, Bristol-Myers Join $27M Funding for Vedanta Bio 12/24/18 Boston
Bio Roundup: CRISPR Babies, Blood Diseases, Big Cancer Nod & More 11/30/18 National
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More 11/16/18 National
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More 10/26/18 National
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front 10/23/18 National
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive’s End 10/19/18 National
A Year Early, Merck Touts Good Kidney Cancer News to Push Rival BMS 10/18/18 New York
Bristol Stumbles in Lung Cancer Again as Rivals Play Catch-Up 10/12/18 New York
FDA’s Latest Cancer Approval Underscores Immunotherapy Nobel Prize 10/01/18 National
Bristol Nabs Immunotherapy’s First FDA Nod for Small Cell Lung Cancer 08/17/18 New York
Bio Roundup: Alnylam’s Moment, Read on Rebates, Skinny Plans & More 08/03/18 National
Page 1 of 4 next page »